tubercidin has been researched along with Congenital Zika Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernatchez, JA; Li, J; Li, R; Luan, Y; Siqueira-Neto, JL; Tran, LT | 1 |
| Bassetto, M; Basso, M; Brancale, A; Bugert, JJ; Cima, CM; Friese, D; Salerno, M; Schwarze, F | 1 |
| Kaptein, SJ; Marques, RE; Neyts, J; Schols, D; Verbeken, E; Zmurko, J | 1 |
| Elfiky, AA | 1 |
1 review(s) available for tubercidin and Congenital Zika Syndrome
| Article | Year |
|---|---|
Drugs for the Treatment of Zika Virus Infection.
Topics: Animals; Antiviral Agents; Drug Development; Drug Discovery; Humans; Viral Vaccines; Zika Virus; Zika Virus Infection | 2020 |
3 other study(ies) available for tubercidin and Congenital Zika Syndrome
| Article | Year |
|---|---|
Novel Nucleoside Analogues as Effective Antiviral Agents for Zika Virus Infections.
Topics: Adenosine; Antiviral Agents; Autophagy; Cell Adhesion; Host-Pathogen Interactions; Humans; Nucleosides; Small Molecule Libraries; Tubercidin; Virus Replication; Zika Virus; Zika Virus Infection | 2020 |
The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Disease Models, Animal; Male; Mice; Tubercidin; Vero Cells; Virus Replication; Zika Virus; Zika Virus Infection | 2016 |
Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials.
Topics: Antiviral Agents; Clinical Trials as Topic; Computer Simulation; Drug Discovery; Enzyme Inhibitors; Guanosine Monophosphate; Hepacivirus; Hepatitis C; Humans; Molecular Docking Simulation; RNA-Dependent RNA Polymerase; Tubercidin; Zika Virus; Zika Virus Infection | 2016 |